Literature DB >> 10742136

De-mystifying the mechanism(s) of maspin.

M J Hendrix.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10742136     DOI： 10.1038/74624

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  9 in total

1.  Maspin suppresses survival of lung cancer cells through modulation of Akt pathway.

Authors:  Eunsook Nam; Chaehwa Park
Journal:  Cancer Res Treat       Date:  2010-03-31       Impact factor: 4.679

2.  Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells.

Authors:  Sumaira Amir; Naira V Margaryan; Valerie Odero-Marah; Zhila Khalkhali-Ellis; Mary J C Hendrix
Journal:  Cancer Biol Ther       Date:  2005-04-21       Impact factor: 4.742

Review 3.  P53 mutations in thyroid carcinoma: tidings from an old foe.

Authors:  N R Farid
Journal:  J Endocrinol Invest       Date:  2001 Jul-Aug       Impact factor: 4.256

4.  Proteomic dissection of dome formation in a mammary cell line: role of tropomyosin-5b and maspin.

Authors:  I Zucchi; L Bini; R Valaperta; A Ginestra; D Albani; L Susani; J C Sanchez; S Liberatori; B Magi; R Raggiaschi; D F Hochstrasser; V Pallini; P Vezzoni; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

Review 5.  Cancer proteomics by quantitative shotgun proteomics.

Authors:  Emily I Chen; John R Yates
Journal:  Mol Oncol       Date:  2007-09       Impact factor: 6.603

6.  Discrepancy between mRNA and protein expression of tumour suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid arthritis.

Authors:  J Schedel; O Distler; M Woenckhaus; R E Gay; B Simmen; B A Michel; U Müller-Ladner; S Gay
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

7.  Expression of Ets-1, Ang-2 and maspin in ovarian cancer and their role in tumor angiogenesis.

Authors:  Zijing Lin; Yu Liu; Yuhui Sun; Xiuping He
Journal:  J Exp Clin Cancer Res       Date:  2011-03-25

8.  Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways.

Authors:  Mohammadreza Zamanian; Lama Abdel Qader Hamadneh; Abhi Veerakumarasivam; Sabariah Abdul Rahman; Shamarina Shohaimi; Rozita Rosli
Journal:  Cancer Cell Int       Date:  2016-07-13       Impact factor: 5.722

Review 9.  Double Agent: SPDEF Gene with Both Oncogenic and Tumor-Suppressor Functions in Breast Cancer.

Authors:  Ting Ye; Jia Feng; Xue Wan; Dan Xie; Jinbo Liu
Journal:  Cancer Manag Res       Date:  2020-05-25       Impact factor: 3.989
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.